Use of Intralesional and Perilesional Human Recombinant Epidermal Growth Factor (hrEGF) in the Local Treatment of Venous Ulcer – Review Article – Expert Recommendation

Maria Teresa Cacua Sanchez1 Ambulatory Surgery Center, Kennedy Hospital, Vascular Laboratory SURA, Bogotá, ColombiaCorrespondence[email protected]

Lina M Vargas Abello2 Lumina Vein & Aesthetic Institute, Windermere, FL, USA

Álvaro Orrego3 Laser & Veins Clinic, Viña del Mar, Chile

Paola Ortiz4 Uruguay Vein Center, Universidad de la República Oriental de Uruguay, Montevideo, Uruguay

Héctor Segura5 Vascular and Endovascular Surgery Department, Hospital Español, Mexico City, Mexico

Jhon Jairo Berrio Caicedo6 Universidad Del Valle, San José de Buga Hospital Foundation, Buga, Colombia

Luz Marina Zuluaga7 San Juan de Dios Hospital, Cartago Valle, Colombia

José Ordoñez8 Department of Vascular Surgery, Fundación Santa Fe, Bogotá, Colombia

José Ignacio Fernández Montequin9 National Institute of Angiology and Vascular Surgery, Havana, Cuba

Jorge Ulloa10 Department of Vascular Surgery, Fundación Santa Fe de Bogotá, Universidad de los Andes, Bogota, Colombia

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.